GDF15 and neoplasm: In addition, it has been reported that HY-PDT can inhibit the growth of tumor cells by reducing the level of growth differentiation factor 15 (GDF-15) and disturbs the surviving inhibitor YM155, which is also sensitive to paclitaxel (Kuchárová et al., 2015; Gyurászová et al., 2016).